Please read the following information about this continuing pharmacy education (CPE) activity before accessing the presentation using the Launch Presentation button located below the Agenda.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit (ACPE activity #204-000-11-448-H05P).
Methods and Format
This is an online activity consisting of audio and slides for one presentation, a post-test, and an activity evaluation tool. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live activity. Participants must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing pharmacy education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 2 hours. This activity is provided free of charge.
This knowledge-based continuing pharmacy education activity was planned to meet the needs of pharmacists, including clinicians, managers, and educators who are interested in learning more about ensuring the safe compounding and administration of intravenous medications.
This educational activity will discuss the current status of standards for compounding sterile preparations, taking into account the impact of drug shortages on the use of compounding pharmacies. Strategies for ensuring patient safety with the use of compounded i.v. medications will be reviewed. The faculty will provide clinical pearls and practical advice that the pharmacy department can use to improve the preparation and administration of compounded sterile preparations.
After participating in this knowledge-based CPE activity, participants should be able to
- Summarize the current status of standards for compounding sterile preparations, as well as national efforts to collect intravenous medication error data.
- Describe scenarios that could result in errors in compounding intravenous medications and strategies to ensure patient safety.
- Describe the pharmacy staff's role in ensuring compliance with USP Chapter <797> standards.
- Describe practical ways to avoid risk for error in sterile compounding, including tips for evaluating an outsourcing pharmacy.
- Describe evolving medication safety technologies to support sterile compounding.
Director, Pharmacy Services
Cedars-Sinai Medical Center
Assistant Dean, Clinical Pharmacy
UCSF School of Pharmacy
Los Angeles, California
Rita Shane, Pharm.D., FASHP, FCSHP, is Director of Pharmacy Services at Cedars-Sinai Medical Center, a 950-bed acute- and tertiary-care, teaching institution in Los Angeles, California, and Assistant Dean, Clinical Pharmacy Services at the University of California, San Francisco (UCSF), School of Pharmacy. She is responsible for more than 300 staff members. Dr. Shane's goal is to ensure that wherever patients need care, there is a demand for pharmacists to ensure optimal management of medications.
Over the years, Dr. Shane has been recognized for her passion for the profession. She is the recipient of the 2007 California Society of Health-System Pharmacists (CSHP) Pharmacist of the Year Award and the 2007 Distinguished Service Award from the ASHP Section of Pharmacy Practice Managers. Dr. Shane was the 2005 recipient of the ASHP Distinguished Leadership Award and the 1995 recipient of the John Webb Visiting Professorship in Hospital Pharmacy for management excellence.
Dr. Shane is a co-investigator in two research studies in collaboration with the UCSF School of Pharmacy and approved by the California State Board of Pharmacy to demonstrate the safety and importance of allowing technicians to check technician-filled medication cassettes in hospitals. She also worked collaboratively with CSHP to author language in support of this regulatory change, which was approved by the State of California effective in January 2007. She was part of the research team awarded a 2000 National Patient Safety Foundation Research Award for a randomized, controlled study of the impact of dedicated medication nurses on the rate of medication administration errors, which was subsequently published in the Archives of Internal Medicine.
Dr. Shane recently served as the United States facilitator at the Global Conference on the Future of Hospital Pharmacy held during the 68th Congress of the International Pharmaceutical Federation and was responsible for reviewing the international literature on the subject of medication administration. She is an investigator in a multicenter study of medications errors recovered by emergency department pharmacists, which was published in the Annals of Emergency Medicine. Throughout her career, Dr. Shane has participated on committees and task forces at the state and national level. She recently was a member of the American Hospital Association Committee on Health Professions and the National Quality Forum Patient Safety Advisory Committee. She is the ASHP representative to The Joint Commission Hospital Professional Technical Committee. She has presented at local, state, national, and international meetings and has published a number of papers in the pharmacy literature, including one of the background papers for the recent ASHP Pharmacy Practice Model Summit.
Chief of Pharmacy Services
Brigham and Women's Hospital
William W. Churchill, M.S., B.S.Pharm., is Chief of Service for the Department of Pharmacy Services at the Brigham and Women's Hospital in Boston, Massachusetts, where he is responsible for leadership of the pharmacy department and Anticoagulation Management Services. Mr. Churchill serves Brigham and Women's Hospital as the Chairperson of the Drug Safety Committee, Vice Chairperson of the Pharmacy and Therapeutics Committee, and Co-Chairperson of the eMAR/Bar Code Scanning Project Team. Mr. Churchill is the Vice Chairperson of the University Hospital Consortium's Pharmacy Executive Committee and serves on the Novation Pharmacy Executive Committee.
Mr. Churchill received his Bachelor of Pharmacy and Master of Science degrees from Northeastern University, Boston. He is adjunct Clinical Professor of Pharmacy Practice at Northeastern University, Bouve College of Health Sciences. Mr. Churchill also holds an appointment as Visiting Professor at the University of London School Of Pharmacy. Mr. Churchill's main areas of interest and practice include improving the safety and efficiency of medication administration systems, design and implementation of medication safety related technology, robotics, and automation, including the expanding the role of the clinical pharmacy specialist through the use of medication safety technology.
For his efforts in improving medication safety worldwide, Mr. Churchill was awarded the 2007 American Society of Health-System Pharmacists (ASHP) Distinguished Leadership Award. In 2008, he was selected as the Massachusetts Health System Pharmacist of the Year. In 2009, Mr. Churchill was selected by ASHP and Northeastern University as the 25th John W. Webb Lecture Award winner. This annual award recognizes a health-system pharmacy practitioner or educator who has shown extraordinary dedication to fostering excellence in pharmacy leadership. In 2010, Mr. Churchill was awarded the Boston Business Journal's prestigious Healthcare Champion Award for Innovation.
Clinical IQ, LLC
Madison, New Jersey
Eric S. Kastango, M.B.A., B.S.Pharm., FASHP, is president of Clinical IQ, LLC, a health care consulting firm that assists clients who require expertise in the area of USP Chapter <797>, aseptic processing (pharmacy and pharmaceutical based), medical device manufacturing, and the implementation of extemporaneous compounding quality systems.
Mr. Kastango received his Bachelor of Science in Pharmacy degree from the Massachusetts College of Pharmacy and Allied Health Sciences and his Master of Business Administration degree from the University of Phoenix. He completed 65 hours of training in nuclear pharmacy at Purdue University and 80 hours of didactic training for the Six Sigma-Green Belt certification that he started with BD Medical Systems. Since 1980, he has practiced pharmacy in a number of practice settings, including hospitals, community, and home care, and in a number of different of roles, including the Corporate Vice President of Pharmacy Services for Coram Healthcare Corporation. He has also managed a FDA-registered cGMP manufacturing operation for Baxter Healthcare Corporation.
He is an active member and Fellow of the American Society of Health-System Pharmacists and has served on the ASHP's Council of Educational Affairs. He also served on the USP Sterile Compounding Committee from 2005-2010. He was recently re-elected to the 2010-2015 USP Council of Experts Compounding Expert Committee. He has been invited to speak at over 150 national and international presentations on a variety of pharmacy practice topics, including sterile product preparation, pharmacy compounding errors, and quality systems.
Mr. Kastango is author of The 2004 ASHP Discussion Guide on Sterile Preparation: Summary and Implementation of USP Chapter <797>, Sterile Product Preparation: A Multimedia Learning Tool (CD-ROM), and ASHP's web-based compliance advisor gap analysis tool for USP Chapter <797>. He is a contributing author of three chapters for the second edition of Compounding Sterile Preparations and a frequent contributor to the American Journal of Health-System Pharmacy, Pharmacy Purchasing and Products, International Journal of Pharmaceutical Compounding, and Infusion (Journal of the National Home Infusion Association).
In accordance with the Accreditation Council for Continuing Medical Education's Standards for Commercial Support and the Accreditation Council for Pharmacy Education's Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual's participation in development of content for an educational activity.
The faculty and planners report the following relationships:
Rita Shane, Pharm.D., FASHP, FCSHP, Activity Chair
Dr. Shane declares that she has no relationships pertinent to this activity.
William W. Churchill, M.S., B.S.Pharm.
Mr. Churchill declares that he has no relationships pertinent to this activity.
Eric S. Kastango, M.B.A., B.S.Pharm., FASHP
Mr. Kastango declares that he has no relationships pertinent to this activity.
Susan R. Dombrowski, M.S., B.S.Pharm.
Ms. Dombrowski declares that she has no relationships pertinent to this activity.
Ron DeChant, M.S., B.S.Pharm.
Mr. DeChant declares that he has no relationships pertinent to this activity.
ASHP staff has no relevant financial relationships to disclose.
This activity is supported by an educational grant from Hospira, Inc.
Agenda (120 minutes total)*
Accidents Still Happen: Overview of Current Initiatives for Ensuring the Safety of Compounded I.V. Medications
Rita Shane, Pharm.D., FASHP, FCSHP
Staying the Course with USP Chapter <797>: Empowering Your Staff to be the Front Line of Defense in Ensuring Sterile Compounding Safety and Clinical Pearls: Tips for Identifying Potential Sources of Error in Your Sterile Compounding Service
Eric S. Kastango, M.B.A., B.S.Pharm., FASHP
Strategies for Ensuring the Safe Compounding of Intravenous Medication and Clinical Pearls: Sterile Compounding Quality and Safety Tips for the Pharmacy Department
William W. Churchill, M.S., B.S.Pharm.
Faculty Discussion and Audience Questions (optional)
*Allow additional time to complete the post-test and evaluation.
Download Assessment and Handout
Planned and coordinated by ASHP Advantage
Activity Resources and Announcements
- Conducted as a Midday Symposium and Live Webcast on December 6, 2011, at the ASHP Midyear Clinical Meeting in New Orleans, Louisiana
- Before beginning this activity, we recommend downloading the activity resources
- Audience response questions will display answers of webcast participants on date of live activity
- Click "Begin Activity" to proceed